LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

DaVita Inc

Cerrado

SectorSanidad

137.91 0.22

Resumen

Variación precio

24h

Actual

Mínimo

137.14

Máximo

139.47

Métricas clave

By Trading Economics

Ingresos

-117M

232M

Ventas

-71M

3.2B

P/B

Media del Sector

13.334

51.198

BPA

2

Margen de beneficios

7.204

Empleados

76,000

EBITDA

-131M

598M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+15.25% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-2.3B

10B

Apertura anterior

137.69

Cierre anterior

137.91

Noticias sobre sentimiento de mercado

By Acuity

19%

81%

38 / 380 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

DaVita Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 feb 2025, 19:50 UTC

Principales Movimientos del Mercado

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 mar 2025, 08:19 UTC

Charlas de Mercado

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15 jul 2024, 08:17 UTC

Charlas de Mercado

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Comparación entre iguales

Cambio de precio

DaVita Inc previsión

Precio Objetivo

By TipRanks

15.25% repunte

Estimación a 12 Meses

Media 158.75 USD  15.25%

Máximo 169 USD

Mínimo 145 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DaVita Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

0

Comprar

3

Mantener

1

Vender

Puntuación técnica

By Trading Central

142.36 / 144.275Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

38 / 380 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.